[go: up one dir, main page]

ES1265629U - Cosmetic composition of liposomes containing a quaternized derivative of 18-methyl eicosanoic acid (Machine-translation by Google Translate, not legally binding) - Google Patents

Cosmetic composition of liposomes containing a quaternized derivative of 18-methyl eicosanoic acid (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES1265629U
ES1265629U ES202130082U ES202130082U ES1265629U ES 1265629 U ES1265629 U ES 1265629U ES 202130082 U ES202130082 U ES 202130082U ES 202130082 U ES202130082 U ES 202130082U ES 1265629 U ES1265629 U ES 1265629U
Authority
ES
Spain
Prior art keywords
weight
composition
cosmetic composition
translation
machine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES202130082U
Other languages
Spanish (es)
Other versions
ES1265629Y (en
Inventor
Rodriguez Daniel Pando
Bartolome Rebeca Alonso
Garcia Ana María Coto
Arias Lucía Martinez
Gonzalez Alejandro Llamedo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Cosmeticos Lamarvi S A U
Nanovex Biotechnologies S L
Nanovex Biotechnologies SL
Original Assignee
Laboratorios Cosmeticos Lamarvi S A U
Nanovex Biotechnologies S L
Nanovex Biotechnologies SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Cosmeticos Lamarvi S A U, Nanovex Biotechnologies S L, Nanovex Biotechnologies SL filed Critical Laboratorios Cosmeticos Lamarvi S A U
Priority to ES202130082U priority Critical patent/ES1265629Y/en
Publication of ES1265629U publication Critical patent/ES1265629U/en
Application granted granted Critical
Publication of ES1265629Y publication Critical patent/ES1265629Y/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)

Abstract

Una composición cosmética en forma de una dispersión acuosa y estable de liposomas, caracterizada porque tiene la siguiente composición: a. entre 3,00 y 4,00% en peso de fosfatidilcolina pura, b. entre 0,10 y 1,00% en peso de fosfatidilcoliona hidrogenada, c. entre 5,60 y 8,00% en peso de manitol; d. entre 2,00 y 5,00% en peso de glicerol, e. entre 1,00 y 2,00% en peso de colesterol, f. entre 0,50 y 1,00% en peso de sorbato potásico, g. entre 0,50 y 1,00% en peso de benzoato sódico, h. entre 0,05 y 0,20% en peso de sal de origen marino, i. entre 0,60 y 1,20% en peso de dipropilenglicol, j. entre 0,40 y 0,80% en peso de C10-40 Isoalquilamidopropiletildimonium Etosulfato, k. entre 0,30 y 0,60% en peso de ceramida, l. agua hasta l00,00% en peso, donde dichos % en peso son con respecto al peso total de la composición.A cosmetic composition in the form of a stable, aqueous dispersion of liposomes, characterized in that it has the following composition: a. between 3.00 and 4.00% by weight of pure phosphatidylcholine, b. between 0.10 and 1.00% by weight of hydrogenated phosphatidylcholione, c. between 5.60 and 8.00% by weight of mannitol; d. between 2.00 and 5.00% by weight of glycerol, e. between 1.00 and 2.00% by weight of cholesterol, f. between 0.50 and 1.00% by weight of potassium sorbate, g. between 0.50 and 1.00% by weight of sodium benzoate, h. between 0.05 and 0.20% by weight of salt of marine origin, i. between 0.60 and 1.20% by weight of dipropylene glycol, j. between 0.40 and 0.80% by weight of C10-40 Isoalkylamidopropylethyldimonium Etosulfate, k. between 0.30 and 0.60% by weight of ceramide, l. water up to 100.00% by weight, where said% by weight are relative to the total weight of the composition.

Description

DESCRIPCIÓNDESCRIPTION

Composición cosmética de liposomas que contienen un derivado cuaternizado de ácido 18-metil eicosanoicoCosmetic composition of liposomes containing a quaternized derivative of 18-methyl eicosanoic acid

ANTECEDENTESBACKGROUND

La presente invención pertenece al campo de la cosmética, concretamente al de aplicaciones capilares, y consta de un liposoma que contiene un derivado cuaternizado de ácido 18-metil eicosanoico (18-MEA).The present invention belongs to the field of cosmetics, specifically to that of hair applications, and consists of a liposome containing a quaternized derivative of 18-methyl eicosanoic acid (18-MEA).

DESCRIPCIÓN DE LA INVENCIÓNDESCRIPTION OF THE INVENTION

Los liposomas son vesículas esféricas con una membrana compuesta de una doble capa de fosfolípidos, que constan de partes hidrosolubles y liposolubles. Los liposomas son osmóticamente activos y estables y presentan numerosas ventajas, como su buen poder de solubilización o su capacidad de aumentar la estabilidad de una molécula contenida en ellos debido a la carga eléctrica de su superficie. Además, son biodegradables, biocompatibles y no inmunogénicos y exhiben una buena estabilidad coloidal, química y biológica.Liposomes are spherical vesicles with a membrane composed of a double layer of phospholipids, consisting of water-soluble and fat-soluble parts. Liposomes are osmotically active and stable and have numerous advantages, such as their good solubilization power or their ability to increase the stability of a molecule contained in them due to the electrical charge on their surface. Furthermore, they are biodegradable, biocompatible and non-immunogenic and exhibit good colloidal, chemical and biological stability.

La presente invención se refiere a una composición cosmética que comprende una solución acuosa y estable de liposomas que contienen un derivado cuaternizado de 18-MEA, el lípido principal de la superficie del cabello y que, por tanto, confiere una carga catiónica al liposoma, lo que permite una adhesión al cabello y posterior liberación de los activos encaspulados, mientras brinda protección y ayuda al cabello a recuperar o mantener su aspecto saludable. Dicho derivado cuaternizado de 18-MEA es C10-40 Isoalquilamidopropiletildimonium Etosulfato, también llamado 3-(1-oxo-C10-40-isoalquil)amino-N-etil-N,N-dimetilpropanamino etil sulfato.The present invention relates to a cosmetic composition comprising a stable, aqueous solution of liposomes containing a quaternized derivative of 18-MEA, the main lipid on the hair surface and which, therefore, confers a cationic charge on the liposome, thereby that allows adhesion to the hair and subsequent release of the encapulated assets, while providing protection and helping the hair to regain or maintain its healthy appearance. Said quaternized derivative of 18-MEA is C10-40 Isoalkylamidopropylethyldimonium Ethosulfate, also called 3- (1-oxo-C10-40-isoalkyl) amino-N-ethyl-N, N-dimethylpropanamino ethyl sulfate.

Asimismo, esta composición contiene sal de origen marino, preferiblemente del Mar Muerto de Jordania, la cual contiene minerales esenciales que aportan propiedades de gran interés para el cabello.Also, this composition contains salt of marine origin, preferably from the Dead Sea of Jordan, which contains essential minerals that provide properties of great interest to the hair.

Así, la presente invención se refiere a una composición cosmética para uso capilar, en forma de una dispersión acuosa y estable de liposomas, caracterizada porque contiene el derivado cuaternizado de 18-MEA, C10-40 Isoalquilamidopropiletildimonium Etosulfato en una proporción de entre 0,40 y 0,80 % en peso con respecto al peso total de la composición. Thus, the present invention refers to a cosmetic composition for hair use, in the form of an aqueous and stable dispersion of liposomes, characterized in that it contains the quaternized derivative of 18-MEA, C10-40 Isoalkylamidopropylethyldimonium Etosulfate in a proportion of between 0.40 and 0.80% by weight with respect to the total weight of the composition.

En una realización preferida, el contenido del derivado cuaternizado de 18-MEA es de entre 0,50 y 0,70 % en peso con respecto al peso total de la composición.In a preferred embodiment, the content of the quaternized derivative of 18-MEA is between 0.50 and 0.70% by weight with respect to the total weight of the composition.

En una realización preferida de la invención, la composición comprende:In a preferred embodiment of the invention, the composition comprises:

a. entre 3,00 y 4,00 % en peso de fosfatidilcolina pura,to. between 3.00 and 4.00% by weight of pure phosphatidylcholine,

b. entre 0,10 y 1,00 % en peso de fosfatidilcoliona hidrogenada,b. between 0.10 and 1.00% by weight of hydrogenated phosphatidylcolione,

c. entre 5,60 y 8,00 % en peso de manitol,c. between 5.60 and 8.00% by weight of mannitol,

d. entre 2,00 y 5,00 % en peso de glicerol,d. between 2.00 and 5.00% by weight of glycerol,

e. entre 1,00 y 2,00 % en peso de colesterol,and. between 1.00 and 2.00% by weight of cholesterol,

f. entre 0,50 y 1,00 % en peso de sorbato potásico,F. between 0.50 and 1.00% by weight of potassium sorbate,

g. entre 0,50 y 1,00 % en peso de benzoato sódico,g. between 0.50 and 1.00% by weight of sodium benzoate,

h. entre 0,05 y 0,20 % en peso de sal de origen marino,h. between 0.05 and 0.20% by weight of salt of marine origin,

i. entre 0,60 y 1,20 % en peso de dipropilenglicol,i. between 0.60 and 1.20% by weight of dipropylene glycol,

j. entre 0,40 y 0,80 % en peso de C10-40 Isoalquilamidopropiletildimonium Etosulfato, k. entre 0,30 y 0,60 % en peso de ceramida,j. between 0.40 and 0.80% by weight of C10-40 Isoalkylamidopropylethyldimonium Etosulfate, k. between 0.30 and 0.60% by weight of ceramide,

l. agua hasta 100,00 % en peso,l. water up to 100.00% by weight,

donde dichos % en peso son con respecto al peso total de la composición.where said% by weight are with respect to the total weight of the composition.

En una realización más preferida de la invención, la composición comprende:In a more preferred embodiment of the invention, the composition comprises:

a. 3,4 % en peso de fosfatidilcolina pura,to. 3.4% by weight of pure phosphatidylcholine,

b. 0,80 % en peso de fosfatidilcoliona hidrogenada,b. 0.80% by weight of hydrogenated phosphatidylcholione,

c. 5,6 % en peso de manitol,c. 5.6% by weight of mannitol,

d. 3,2 % en peso de glicerol,d. 3.2% by weight of glycerol,

e. 1,8 % en peso de colesterol,and. 1.8% by weight of cholesterol,

f. 0,6 % en peso de sorbato potásico,F. 0.6% by weight of potassium sorbate,

g. 0,6 % en peso de benzoato sódico,g. 0.6% by weight of sodium benzoate,

h. 0,1 % en peso de sal de origen marino,h. 0.1% by weight of salt of marine origin,

i. 0,84 % en peso de dipropilengligol,i. 0.84% by weight of dipropylene glycol,

j. 0,56 % en peso de C10-40 Isoalquilamidopropiletildimonium Etosulfato,j. 0.56% by weight of C10-40 Isoalkylamidopropylethyldimonium Ethosulfate,

k. 0,40 % en peso de ceramida,k. 0.40% by weight of ceramide,

l. agua hasta 100,00 % en peso,l. water up to 100.00% by weight,

donde dichos % en peso son con respecto al peso total de la composición.where said% by weight are with respect to the total weight of the composition.

EJEMPLOSEXAMPLES

Esta invención se entenderá mejor por referencia a los ejemplos a continuación, pero aquellos expertos en la técnica apreciaran fácilmente que los ejemplos específicos detallados solamente son ilustrativos de la invención. This invention will be better understood by reference to the examples below, but those skilled in the art will readily appreciate that the detailed specific examples are only illustrative of the invention.

Ejemplo 1: Composición y forma de prepararlaExample 1: Composition and how to prepare it

Figure imgf000004_0001
Figure imgf000004_0001

* Todos los porcentajes son en peso con respecto al peso total de la composición.* All percentages are by weight with respect to the total weight of the composition.

La composición se preparó de la siguiente forma:The composition was prepared as follows:

. Se mezclaron la fosfatidilcolina, la fosfatidilcolina hidrogenada, la ceramida, el C10-40 Isoalquilamidopropiletildimonium Etosulfato, el dipropilenglicol y el colesterol, disueltos en etanol, con el manitol.. Phosphatidylcholine, hydrogenated phosphatidylcholine, ceramide, C10-40 Isoalkylamidopropylethyldimonium Ethosulfate, dipropylene glycol and cholesterol, dissolved in ethanol, were mixed with mannitol.

. Se secó la mezcla del punto 1 a vacío a temperatura controlada de 40 °C hasta eliminar el etanol.. The mixture from point 1 was dried under vacuum at a controlled temperature of 40 ° C until the ethanol was removed.

. El sólido formado se hidrató con una solución acuosa conteniendo el glicerol, el benzoato sódico, el sorbato potásico y la sal marina en agua ultra pura y se dejó hidratar durante 1h a 58 °C.. The solid formed was hydrated with an aqueous solution containing glycerol, sodium benzoate, potassium sorbate and sea salt in ultra pure water and allowed to hydrate for 1h at 58 ° C.

. La mezcla obtenida en el punto 3 se mezcló con un agitador de hélice a 600 rpm a temperatura controlada de 40 °C durante 30 min. . The mixture obtained in point 3 was mixed with a propeller stirrer at 600 rpm at a controlled temperature of 40 ° C for 30 min.

5. La disolución se homogeneizó a 15000 rpm durante 30 min a temperatura controlada de 40 °C.5. The solution was homogenized at 15000 rpm for 30 min at a controlled temperature of 40 ° C.

La composición así obtenida es homogénea y estable y constituye un excelente producto para la salud del cabello. The composition thus obtained is homogeneous and stable and constitutes an excellent product for hair health.

Claims (2)

REIVINDICACIONES 1. Una composición cosmética en forma de una dispersión acuosa y estable de liposomas, caracterizada porque tiene la siguiente composición:1. A cosmetic composition in the form of a stable, aqueous dispersion of liposomes, characterized in that it has the following composition: a. entre 3,00 y 4,00 % en peso de fosfatidilcolina pura,to. between 3.00 and 4.00% by weight of pure phosphatidylcholine, b. entre 0,10 y 1,00 % en peso de fosfatidilcoliona hidrogenada,b. between 0.10 and 1.00% by weight of hydrogenated phosphatidylcolione, c. entre 5,60 y 8,00 % en peso de manitol,c. between 5.60 and 8.00% by weight of mannitol, d. entre 2,00 y 5,00 % en peso de glicerol,d. between 2.00 and 5.00% by weight of glycerol, e. entre 1,00 y 2,00 % en peso de colesterol,and. between 1.00 and 2.00% by weight of cholesterol, f. entre 0,50 y 1,00 % en peso de sorbato potásico,F. between 0.50 and 1.00% by weight of potassium sorbate, g. entre 0,50 y 1,00 % en peso de benzoato sódico,g. between 0.50 and 1.00% by weight of sodium benzoate, h. entre 0,05 y 0,20 % en peso de sal de origen marino,h. between 0.05 and 0.20% by weight of salt of marine origin, i. entre 0,60 y 1,20 % en peso de dipropilenglicol,i. between 0.60 and 1.20% by weight of dipropylene glycol, j. entre 0,40 y 0,80 % en peso de C10-40 Isoalquilamidopropiletildimonium Etosulfato, k. entre 0,30 y 0,60 % en peso de ceramida,j. between 0.40 and 0.80% by weight of C10-40 Isoalkylamidopropylethyldimonium Etosulfate, k. between 0.30 and 0.60% by weight of ceramide, l. agua hasta 100,00 % en peso,l. water up to 100.00% by weight, donde dichos % en peso son con respecto al peso total de la composición.where said% by weight are with respect to the total weight of the composition. 2. La composición según la reivindicación anterior, donde la composición comprende:2. The composition according to the preceding claim, wherein the composition comprises: a. 3,4 % en peso de fosfatidilcolina pura,to. 3.4% by weight of pure phosphatidylcholine, b. 0,80 % en peso de fosfatidilcoliona hidrogenada,b. 0.80% by weight of hydrogenated phosphatidylcholione, c. 5,6 % en peso de manitol,c. 5.6% by weight of mannitol, d. 3,2 % en peso de glicerol,d. 3.2% by weight of glycerol, e. 1,8 % en peso de colesterol,and. 1.8% by weight of cholesterol, f. 0,6 % en peso de sorbato potásico,F. 0.6% by weight of potassium sorbate, g. 0,6 % en peso de benzoato sódico,g. 0.6% by weight of sodium benzoate, h. 0,1 % en peso de sal de origen marino,h. 0.1% by weight of salt of marine origin, i. 0,84 % en peso de dipropilenglicol,i. 0.84% by weight of dipropylene glycol, j. 0,56 % en peso de C10-40 Isoalquilamidopropiletildimonium Etosulfato,j. 0.56% by weight of C10-40 Isoalkylamidopropylethyldimonium Ethosulfate, k. 0,40 % en peso de ceramida,k. 0.40% by weight of ceramide, l. agua hasta 100,00 % en peso,l. water up to 100.00% by weight, donde dichos % en peso son con respecto al peso total de la composición. where said% by weight are with respect to the total weight of the composition.
ES202130082U 2021-01-20 2021-01-20 Cosmetic composition of liposomes containing a quaternized derivative of 18-methyl eicosanoic acid Active ES1265629Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES202130082U ES1265629Y (en) 2021-01-20 2021-01-20 Cosmetic composition of liposomes containing a quaternized derivative of 18-methyl eicosanoic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES202130082U ES1265629Y (en) 2021-01-20 2021-01-20 Cosmetic composition of liposomes containing a quaternized derivative of 18-methyl eicosanoic acid

Publications (2)

Publication Number Publication Date
ES1265629U true ES1265629U (en) 2021-04-19
ES1265629Y ES1265629Y (en) 2021-07-22

Family

ID=75464208

Family Applications (1)

Application Number Title Priority Date Filing Date
ES202130082U Active ES1265629Y (en) 2021-01-20 2021-01-20 Cosmetic composition of liposomes containing a quaternized derivative of 18-methyl eicosanoic acid

Country Status (1)

Country Link
ES (1) ES1265629Y (en)

Also Published As

Publication number Publication date
ES1265629Y (en) 2021-07-22

Similar Documents

Publication Publication Date Title
CN104739658B (en) A kind of Ceramide nanoemulsion and preparation method thereof
US20060110418A1 (en) Water-in-oil emulsions and methods
FR2597345A1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION BASED ON AN AQUEOUS DISPERSION OF LIPID SPHERULES.
JP2003516338A (en) Stabilized antimicrobial agent system and method of making same
EP0020706A1 (en) Water soluble lecithin composition
MX2023014855A (en) Cationic lipids and compositions thereof.
CN108498368A (en) The cosmetic composition for improving the percutaneous permeability of substance for enhancing skin
MX2023012369A (en) Cationic lipids and compositions thereof.
JP2009040697A (en) Cosmetic composition
KR20120065348A (en) Transdermal composition of phosphatidylcholine and method for producing same
MX2022014484A (en) Novel lipids and nanoparticle compositions thereof.
PT85259B (en) Process for the preparation of a skin branding agent
CN105213206B (en) A kind of enoxolone liposome and preparation method thereof
ES1265629U (en) Cosmetic composition of liposomes containing a quaternized derivative of 18-methyl eicosanoic acid (Machine-translation by Google Translate, not legally binding)
JP2007191396A (en) Skin preparation for external use
KR20160012757A (en) Cosmetic composition
WO2006073190A1 (en) Composition for external use
WO2006057166A1 (en) Cosmetic composition for skin
JP7735617B2 (en) Liposome dispersion, and cosmetics and topical skin preparations containing liposome dispersion
TW201914570A (en) Method for preparing positively charged charged liposome and charged liposome
EP0624086B1 (en) Cosmetic composition for adding to bath water
KR101607166B1 (en) Whitening cosmetic composition containing liposomes comprising phosphatidyl ethanolamine and phosphatidyl choline
ES1247839U (en) COSMETIC COMPOSITION OF LIPOSOMES COATED WITH HYDROLYZED SILK FIBROIN (Machine-translation by Google Translate, not legally binding)
CN111629706B (en) Process for the preparation of transparent nanoemulsions comprising lauric oil
ES1306374U (en) COSMETIC COMPOSITION OF LIPOSOMES CONTAINING THE FLAVONOID HESPERIDIN (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
CA1K Utility model application published

Ref document number: 1265629

Country of ref document: ES

Kind code of ref document: U

Effective date: 20210419

FG1K Utility model granted

Ref document number: 1265629

Country of ref document: ES

Kind code of ref document: Y

Effective date: 20210716